Cholesterol, high-density lipoprotein, glucose index as a novel marker for predicting in-stent restenosis after drug-eluting stent implantation in patients with acute coronary syndrome
BackgroundAcute coronary syndrome (ACS) poses a serious health risk, and drug-eluting stent (DES) implantation is widely used to improve prognosis. However, the risk of in-stent restenosis (ISR) persists in some patients. The CHG index, a novel metabolic marker, has not been clearly linked to ISR ri...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-02-01
|
| Серія: | Frontiers in Cardiovascular Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fcvm.2026.1740216/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|